Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-005282-37Phase 4Completed
Phase 4, double-blind trial of vardenafil in erectile dysfunction (ED) (2 arms), sponsored by Bayer. Primary endpoints: Characteristics of responders and non-responders at baseline and Duration of erection with rigidity greater than 70%. Started Jan 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-005282-37.